Relationship of genetic variability and depressive symptoms to adverse events after coronary artery bypass graft surgery

Psychosomatic Medicine

Volumn 70, Issue 9, 2008, Pages 953-959

  Phillips Bute, Barbara ^a   Mathew, Joseph P ^a   Blumenthal, James A ^a   Morris, Richard W ^a   Podgoreanu, Mihai V ^a   Smith, Michael ^a   Stafford Smith, Mark ^a   Grocott, Hilary P ^a   Schwinn, Debra A ^a   Newman, Mark F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CABG surgery; Depression; Genetic variability; Monoamine oxidase A; Serotonin; Serotonin transporter gene

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; SEROTONIN TRANSPORTER; AMINE OXIDASE (FLAVIN CONTAINING);

ALLELE; ARTICLE; BLOOD SAMPLING; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEPRESSION; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; AGED; CARDIOPULMONARY BYPASS; COHORT ANALYSIS; ENZYMOLOGY; ETHNIC GROUP; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; INCIDENCE; MIDDLE AGED; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROMOTER REGION; PSYCHOLOGICAL ASPECT; RESTENOSIS; RISK FACTOR; VARIABLE NUMBER OF TANDEM REPEAT;

AGED; ALLELES; CARDIOPULMONARY BYPASS; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; DEPRESSION; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MONOAMINE OXIDASE; MUTAGENESIS, INSERTIONAL; POSTOPERATIVE COMPLICATIONS; PROMOTER REGIONS, GENETIC; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 59849126325     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e318187aee6     Document Type: Article

References (34)

1. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 2003;65:201-210
2. Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 1996; 94:3123-3129
3. Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, van Eijk JT, van Tilburg W. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001;58:221-227
4. Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Talajic M, Bourassa MG. Social support, depression, and mortality during the first year after myocardial infarction. Circulation 2000;101:1919-1924 (Pubitemid 30225272)
5. Bush D, Ziegelstein R, Patel U, Thombs B, Ford D, Fauerback J, MCCann U, Stewart K, Tsilidis K, Patel A, Feuerstein C, Bass E. Post-Myocardial Infarction Depression. Summary, Evidence Report/ Technology Assessment: Number 123. AHRQ Publication Number 05-EO18-1 2005. Rockville, MD: Agency for Healthcare Research and Quality; 2005.
6. Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP. Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet 2001;358:1766-1771
7. Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, Newman MF. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004;66:305-315
8. Burker EJ, Blumenthal JA, Feldman M, Burnett R, White W, Smith LR, Croughwell N, Schell R, Newman M, Reves JG. Depression in male and female patients undergoing cardiac surgery. Br J Clin Psychol 1995;34:119-128
9. Blumenthal JA, Lett HS, Babyak MA, White W, Smith PK, Mark DB, Jones R, Mathew JP, Newman MF, Investigators N. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003;362:604-609 (Pubitemid 37013300)
10. Williams RB, Marchuk DA, Gadde KM, Barefoot JC, Grichnik K, Helms MJ, Kuhn CM, Lewis JG, Schanberg SM, Stafford-Smith M, Suarez EC, Clary GL, Svenson IK, Siegler IC. Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychop-harmacology 2003;28:533-541
11. Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998;103:273-279
12. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-1531
13. Hariri AR, Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci 2006;10: 182-191
14. Jonsson EG, Norton N, Gustavsson JP, Oreland L, Owen MJ, Sedvall GC. A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res 2000;34:239-244
15. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1: 385-401.
16. Jonsson EG, Nothen MM, Gustavsson JP, Neidt H, Bunzel R, Propping P, Sedvall GC. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Psychiatry Res 1998;79:1-9.
17. Gelernter J, Kranzler H, Coccaro EF, Siever LJ, New AS. Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. Am J Psychiatry 1998;155:1332-1338
18. Tang H, Quertermous T, Rodriguez B, Karkia S, Zhu X, Brown E, Schork N, Risch N. Genetic structure, self-identified race/ethnicity, and counfound-ing in case-control association studies. Am J Hum Genet 2005;76:268-275
19. Hannan EL, Wu C, Bennett EV, Carlson RE, Culliford AT, Gold JP, Higgins RSD, Isom OW, Smith CR, Jones RH. Risk stratification of in-hospital mortality for coronary artery bypass graft surgery. J Am Coll Cardiol 2006;47:661-668
20. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, Muller U, Aguet M, Babinet C, Shih JC. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 1763;268:1763-1766
21. Schulze TG, Muller DJ, Krauss H, Scherk H, Ohlraun S, Syagailo YV, Windemuth C, Neidt H, Grassle M, Papassotiropoulos A, Heun R, Nothen MM, Maier W, Lesch KP, Rietschel M. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 2000;96:801-803
22. Amos-Landgraf JM, Cottle A, Plenge RM, Friez M, Schwartz CE, Longshore J, Willard HF. X chromosome-inactivation patterns of 1,005 phenotypically unaffected females. Am J Hum Genet 2006;79:493-499
23. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005;434:400-404
24. Parsey RV, Hastings RS, Oquendo MA, Hu X, Goldman D, Huang YY, Simpson N, Arcement J, Huang Y, Ogden RT, Van Heertum RL, Arango V, Mann JJ. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry 2006;163:48-51.
25. Nakatani D, Sato H, Sakata Y, Shiotani I, Kinjo K, Mizuno H, Shimizu M, Ito H, Koretsune Y, Hirayama A, Hori M, Osaka Acute Coronary Insufficiency Study G. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myo-cardial infarction. Am Heart J 2005;150:652-658
26. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386-389
27. Eley TC, Sugden K, Corsico A, Gregory AM, Sham P, McGuffin P, Plomin R, Craig IW. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 2004;9:908-915
28. Fumeron F, Betoulle D, Nicaud V, Evans A, Kee F, Ruidavets JB, Arveiler D, Luc G, Cambien F. Serotonin transporter gene polymorphism and myocardial infarction: Etude Cas-Temoins de l'Infarctus du Myo-carde (ECTIM). Circulation 2002;105:2943-2945
29. Whyte EM, Pollock BG, Wagner WR, Mulsant BH, Ferrell RE, Mazumdar S, Reynolds CF 3rd. Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression. Am J Psychiatry 2001;158:2074-2076
30. Hranilovic D, Stefulj J, Schwab S, Borrmann-Hassenbach M, Albus M, Jernej B, Wildenauer D. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biol Psychiatry 1090;55:1090-1094
31. Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005;29:8-16.
32. Kilic F, Murphy DL, Rudnick G. A human serotonin transporter mutation causes constitutive activation of transport activity. Mol Pharmacol 2003; 64:440-446
33. Prasad HC, Zhu CB, McCauley JL, Samuvel DJ, Ramamoorthy S, Shelton RC, Hewlett WA, Sutcliffe JS, Blakely RD. Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc Natl Acad Sci U S A 2005;102: 11545-11550
34. Sherwood A, Blumenthal JA, Trivedi R, Johnson KS, O'Connor CM, Adams KF, Jr, Dupree CS, Waugh RA, Bensimhon DR, Gaulden L, Christenson RH, Koch GG, Hinderliter AL. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 2007;167:367-373